These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29867350)

  • 1. Microglial Lectins in Health and Neurological Diseases.
    Siew JJ; Chern Y
    Front Mol Neurosci; 2018; 11():158. PubMed ID: 29867350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
    Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
    Front Oncol; 2016; 6():109. PubMed ID: 27242953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial carbohydrate-binding receptors for neural repair.
    Linnartz B; Bodea LG; Neumann H
    Cell Tissue Res; 2012 Jul; 349(1):215-27. PubMed ID: 22331363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases.
    Wißfeld J; Abou Assale T; Cuevas-Rios G; Liao H; Neumann H
    Front Neurol; 2024; 15():1330874. PubMed ID: 38529039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
    Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
    Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycan Chains of Gangliosides: Functional Ligands for Tissue Lectins (Siglecs/Galectins).
    Ledeen RW; Kopitz J; Abad-Rodríguez J; Gabius HJ
    Prog Mol Biol Transl Sci; 2018; 156():289-324. PubMed ID: 29747818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Siglecs in neurodegenerative diseases.
    Siew JJ; Chern Y; Khoo KH; Angata T
    Mol Aspects Med; 2023 Apr; 90():101141. PubMed ID: 36089405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the recognition of hypermucoviscous
    Campanero-Rhodes MA; Martí S; Hernández-Ortiz N; Cubero M; Ereño-Orbea J; Ardá A; Jiménez-Barbero J; Ardanuy C; Solís D
    Front Immunol; 2024; 15():1436039. PubMed ID: 39148735
    [No Abstract]   [Full Text] [Related]  

  • 10. Alleviation of neurotoxicity by microglial human Siglec-11.
    Wang Y; Neumann H
    J Neurosci; 2010 Mar; 30(9):3482-8. PubMed ID: 20203208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectins and Their Ligand Glycoconjugates in the Central Nervous System Under Physiological and Pathological Conditions.
    Nio-Kobayashi J; Itabashi T
    Front Neuroanat; 2021; 15():767330. PubMed ID: 34720894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siglec functions of microglia.
    Linnartz-Gerlach B; Kopatz J; Neumann H
    Glycobiology; 2014 Sep; 24(9):794-9. PubMed ID: 24833613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation and galectins: a key relationship in neurodegenerative diseases.
    Ramírez Hernández E; Alanis Olvera B; Carmona González D; Guerrero Marín O; Pantoja Mercado D; Valencia Gil L; Hernández-Zimbrón LF; Sánchez Salgado JL; Limón ID; Zenteno E
    Glycoconj J; 2022 Oct; 39(5):685-699. PubMed ID: 35653015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia-derived galectin-3 in neuroinflammation; a bittersweet ligand?
    Rahimian R; Béland LC; Sato S; Kriz J
    Med Res Rev; 2021 Jul; 41(4):2582-2589. PubMed ID: 33733487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siglecs as modulators of macrophage phenotype and function.
    Kukan EN; Fabiano GL; Cobb BA
    Semin Immunol; 2024 May; 73():101887. PubMed ID: 39357273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx.
    Linnartz B; Neumann H
    Glia; 2013 Jan; 61(1):37-46. PubMed ID: 22615186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 "Nanoplex" a Possible Neurotherapeutic?
    Aalinkeel R; Mangum CS; Abou-Jaoude E; Reynolds JL; Liu M; Sundquist K; Parikh NU; Chaves LD; Mammen MJ; Schwartz SA; Mahajan SD
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):133-151. PubMed ID: 28028734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
    Jones C; Virji M; Crocker PR
    Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.